Manufacturer: Plaintiff Cannot Recover Damages for Injuries Allegedly Caused by Enbrel
February 18, 2003
DOCUMENTS
- Motion to Dismiss
LAKE CHARLES, La. - The manufacturers of Enbrel recently moved to dismiss the claims of a Louisiana man who allegedly sustained 'serious and severe side effects' as a result of using the rheumatoid arthritis treatment. John Robert Hite, et al., v. Immunex Corporation, et al., No. CV02-2266-LC (W.D. La., Lake Charles Div.).
Plaintiff John Robert Hite's complaint fails to state a claim for which relief can be granted because it contains a number of fatal flaws, including eight claims that fall outside the scope of the Louisiana Products Liability Act (LPLA). In addition, Hite failed to include all of the …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach